share_log

Goldman Sachs Maintains Neutral on LifeStance Health Gr, Raises Price Target to $9

Benzinga ·  May 19, 2023 08:14

Goldman Sachs analyst Jamie Perse maintains LifeStance Health Gr (NASDAQ:LFST) with a Neutral and raises the price target from $8 to $9.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment